CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 48 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,964,000 | -47.5% | 190,200 | -76.3% | 0.01% | -53.8% |
| Q4 2018 | $9,453,000 | +24.9% | 803,800 | +18.4% | 0.03% | +44.4% |
| Q3 2018 | $7,569,000 | -15.3% | 678,800 | 0.0% | 0.02% | -30.8% |
| Q2 2018 | $8,933,000 | -13.1% | 678,800 | 0.0% | 0.03% | -13.3% |
| Q1 2018 | $10,284,000 | -20.2% | 678,800 | 0.0% | 0.03% | -16.7% |
| Q4 2017 | $12,884,000 | – | 678,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 222,000 | $2,611,000 | 2.47% |
| Orbimed Advisors | 10,425,225 | $122,601,000 | 2.27% |
| NEA Management Company, LLC | 2,707,734 | $31,843,000 | 1.26% |
| Perceptive Advisors | 1,500,000 | $17,640,000 | 0.67% |
| Opaleye Management Inc. | 150,000 | $1,764,000 | 0.66% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,008,001 | $11,854,000 | 0.51% |
| Artal Group S.A. | 850,000 | $9,996,000 | 0.37% |
| Baker Brothers Advisors | 3,724,445 | $43,799,000 | 0.36% |
| PFM Health Sciences, LP | 849,904 | $9,995,000 | 0.27% |
| Fosun International Ltd | 234,526 | $2,627,000 | 0.16% |